
Brendan O'Grady
Executive Vice President, North America Commercial
Brendan O’Grady became Executive Vice President, North America Commercial in November 2017.
From 2016 until November 2017, he served as Chief Commercial Officer, Global Specialty Medicines and served as interim head of Teva’s European Specialty business. Prior to that, he held various senior roles since joining Teva in 2011 as Regional Account Manager, and from 2015 to 2016, he served as President and CEO, Teva North America Generics.
Prior to joining Teva, Mr. O’Grady spent ten years with Sanofi predecessor companies in a variety of commercial and medical affairs roles that began in field sales.
He received his B.S. from Geneseo State University, NY in management science/marketing and holds an M.B.A. from Baker University in Baldwinsville, Kansas.

Kåre Schultz
President & CEO

Richard Daniell
Executive Vice President, European Commercial

Dr. Sven Dethlefs
Executive Vice President, Global Marketing & Portfolio

Eric Drapé
Executive Vice President, Global Operations

Dr. Hafrun Fridriksdottir
Executive Vice President, Global R&D

Gianfranco Nazzi
Executive Vice President, International Markets Commercial

Eli Kalif
Executive Vice President, Chief Financial Officer (CFO)

Mark Sabag
Executive Vice President, Chief Human Resources Officer and Global Communications & Brand

David M. Stark
Executive Vice President, Chief Legal Officer

Nir Baron
Senior Vice President, Chief Internal Auditor

Lori Queisser
Sr. Vice President & Global Compliance Officer
At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:
Copyright © 2019-20 Teva Pharmaceutical Industries Ltd.